Among 1,043 women with cervical cancer enrolled in Botswana from 2013 to 2020, most were diagnosed at stage II or III and two thirds were alive two years later. Seven in ten were living with HIV, and HIV did not change survival.
Published as "Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020". Women with invasive cervical cancer were enrolled prospectively in an observational cohort, and stage, treatment and overall survival were compared between women living with and without HIV.
Most women needed radiotherapy or chemoradiation because of the stage at which they were diagnosed, and women living with HIV, almost all on antiretroviral therapy, did as well as other women.
The authors conclude that cancers rose among people living with HIV during the years in which HIV treatment expanded, and call for prevention and screening aimed at them together with timely HIV and cancer treatment.
The authors judged the approach feasible and efficient and proposed it as an additional screening method for women with limited access to Pap testing; the health ministry's 2018 strategy records its expansion beyond Gaborone.
Shares See-and-treat cervical screening for women living with HIV in Gaborone, 2009 to 2011, Cancer incidence in people with and without HIV in Botswana, 1990 to 2021, Ministry of Health, Botswana, Cervical cancer.
Shares See-and-treat cervical screening for women living with HIV in Gaborone, 2009 to 2011, Ministry of Health, Botswana.
Shares Cancer incidence in people with and without HIV in Botswana, 1990 to 2021, Ministry of Health, Botswana.
Shares Cancer incidence in people with and without HIV in Botswana, 1990 to 2021, Ministry of Health, Botswana.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/